Medical Devices Industry Reports Gel Stent Market | Page 2

REPORT DESCRIPTION
Gel Stent Market – Overview
Rising population above the age of 40 is a major factor driving growth of the market. For instance in 2017, 2.7
million out of 3 million Americans are suffering with glaucoma were aged 40 and older. This is attributed to high
chances of people aged 40 and above suffering from miosis, in which excessive contraction of eye increase in the
elder population. Glaucoma is one of the leading cause for blindness. Increasing demand for minimally invasive
procedures and increasing incidences of glaucoma are other factors that are expected to drive growth of the global
gel stent market over the forecast period. According to Glaucoma Research Society in U.S. in 2017, more than
120,000 are blind from glaucoma.
However, high cost of the gel stent, lack of availability of healthcare professionals and lack of awareness
regarding the technique are factors that hinder growth of the gel stent market.
On the basis of geography, the global gel stent market is segmented into North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the gel stent
market, followed by Europe during the forecast period. The U.S. holds dominant position in the market in this
region due to continuous technological advancements and developed healthcare infrastructure.